CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) hires Thomas Fogarty as Chief Commercial Officer, effectively immediately. Mr. Fogarty brings over two decades of medical ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial ...

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE: RMED), a medical device company focusing on commercializing excimer laser systems to treat vascular and dermatological diseases, ...

CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED) today announced it has entered into a settlement agreement that resolves civil False Claims Act claims asserted by ...

The shares of commercial-stage medical device maker Ra Medical Systems (RMED) have tumbled 92.7% in price over the past year due to investor concerns surrounding the company’s poor financial health.

Peripheral artery disease (PAD) is a narrowing of the arteries in the extremities that reduces blood flow to those limbs. Estimates of prevalence in the US vary widely, from 8.5 million by the CDC, to ...

CARLSBAD, Calif., Following the €1.9 billion ($2.16 billion) purchase of The Spectranetics Corporation by Royal Philips, Ra Medical Systems, makers of cardiovascular and dermatology catheters and ...

In rheumatoid arthritis (RA), the aging process of the immune system is accelerated. Formerly, this phenomenon was suspected to be a consequence of chronic inflammatory activity. However, newer data ...